Indirubin and NAD+ prevent mitochondrial ischaemia/reperfusion damage in fatty livers

European Journal of Clinical Investigation, EarlyView.
Source: European Journal of Clinical Investigation - Category: General Medicine Authors: Source Type: research
More News: General Medicine